Modified R-DAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma

被引：0
|
作者：
Rigacci, L. [1 ]
Fabbri, A. [2 ]
Mappa, S. [1 ]
Nassi, L. [1 ]
Lenoci, M. [2 ]
Puccini, B. [1 ]
Alterini, R. [1 ]
Chitarrelli, I [2 ]
Carrai, V [1 ]
Lauria, F. [2 ]
Bosi, A. [1 ]
机构：
[1] Univ Florence, Florence Azienda Osped, Dept Hematol, I-50121 Florence, Italy
[2] Univ Siena, Siena Azienda Osped, Dept Hematol, I-53100 Siena, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [1] Salvage therapy R-DAOx in patients with relapsed or refractory diffuse large B-CELL lymphoma
    Mappa, S.
    Rigacci, L.
    Nassi, L.
    Puccini, B.
    Alterini, R.
    Carrai, V.
    Bernardi, F.
    Bosi, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
  • [2] Modified R-DHAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
    Fabbri, A.
    Rigacci, L.
    Lenoci, M.
    Mappa, S.
    Puccini, B.
    Nassi, L.
    Chitarrelli, I.
    Gozzetti, A.
    Alterini, R.
    Carrai, V.
    Bosi, A.
    Lauria, F.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 219 - 220
  • [3] Salvage therapy for relapsed/refractory diffuse large B cell lymphoma
    Sesbadri, Tara
    Kuruvilla, Fohn
    Crump, Michael
    Keating, Armand
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (03) : 259 - 267
  • [4] Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab
    Sud, Rohit
    Friedberg, Jonathan W.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1776 - 1780
  • [5] Efficacy of Salvage Radiotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, S.
    Chen, J. Y.
    Cao, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E471 - E472
  • [6] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [7] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [8] Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Yuan, Xianggui
    Li, Xian
    Huang, Yurong
    Jin, Xueli
    Liu, Hui
    Zhao, Aiqi
    Zhang, Weiping
    Qian, Wenbin
    Liang, Yun
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Final results of a phase II trial of R-IDEA as salvage therapy in patients with relapsed/refractory diffuse large B-cell lymphoma
    Kondo, E.
    Yamamoto, K.
    Masunari, T.
    Takizawa, J.
    Miura, K.
    Masaki, Y.
    Matsumura, T.
    Hiramatsu, Y.
    Murakam, J.
    Tsujimura, H.
    Tomita, N.
    Maeda, Y.
    Kanno, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] STATE OF SALVAGE THERAPY FOR RELAPSED AND PRIMARY REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
    Moskowitz, Craig
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : S28 - S29
12345